0.1 (0.03%)
-0.15 (-0.04%) 5.46 pm | 29 Dec 2005
Technical Analyst, Rajat K Bose is of the view that one can expect further gains in Cipla....
1.46 pm | 28 Dec 2005
Cipla has added one more big name to its list of global supply contracts. According to sources, the USD10 billion German drugmaker, Boehringer Ingelhe...
10.19 am | 15 Dec 2005
F&O strategy on HDFC Bank and Cipla by IL&FS Investsmart....
7.51 pm | 02 Dec 2005
Dilip Bhat of Prabhudas Lilladher, feels that Cipla should report almost about Rs 500 crore of profit for 2006....
12.55 pm | 01 Dec 2005
Ambareesh Baliga of Karvy Stock Broking, feels that Ranbaxy Laboratories will not go beyond Rs 400-420 in a hurry....
12.09 pm | 30 Nov 2005
Ajay Srivastava, Dimensions Consulting, feels that Cipla is a good strong story at this point of time....
6.14 pm | 24 Nov 2005
Technical Analyst, Rajat K Bose, feels that further rise like to happen in Cipla....
9.59 am | 23 Nov 2005
Relenza was not an anti-viral medicine that GlaxoSmithKline (GSK) was planning to register in India. But with bird-flu putting the global spotlight on...
2.43 pm | 21 Nov 2005
Technical analyst, Ashwani Gujral, feels that Cipla has a target of Rs 460....
11.17 am | 10 Nov 2005
Technical Analyst, Deepak Mohoni, feels that one can expect short term downswing in Cipla....
10.44 am | 10 Nov 2005
Dipan Mehta, Member, BSE/NSE, feels that one should remain invested in Cipla....
2.32 pm | 08 Nov 2005
Shahina Mukadam of IDBI Capital Markets, feels that one should buy Cipla on declines....
11.18 am | 28 Oct 2005
F&O strategy on Satyam Computer and Cipla by IL&FS Investsmart....
3.56 pm | 27 Oct 2005
Cipla has announced its second quarter results. The company's Q2 net profit is up 27.8% at Rs 122.6 crore from Rs 95.9 crore....
9.02 am | 20 Oct 2005
Pharma giant Roche, which holds the patent for Tamiflu, says it expects an India patent for the drug by mid-November. ...
3.27 pm | 19 Oct 2005
Technical Analyst, Sachin Chavan, feels that Cipla has the potential to go upto Rs 415....
11.46 am | 18 Oct 2005
Technical Analyst, Prakash Gaba feels that Cipla has target of Rs 410....
12.27 pm | 17 Oct 2005
Technical Analyst, Dharmesh Pancholi, feels that Cipla will breakout above Rs 395....
9.41 pm | 14 Oct 2005
Cipla is set to develop the generic version of Roche's anti-influenza drug Tamiflu. Tamiflu costs as much as USD 60 per treatment in the US. An acute ...
5.07 pm | 10 Oct 2005
Devina Mehra of First Global, is of the view that Ranbaxy is fully valued than Dr Reddy's and Cipla....